openPR Logo
Press release

Research on Carotid Body Modulation Devices Market Forecast and Analysis Till 2020

01-20-2017 03:51 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Research on Carotid Body Modulation Devices Market Forecast

Carotid body is a small group of chemoreceptors and support cells located at the fork of the carotid artery, which runs alongside the throat. The Glomus cells are sensors which react differently to variations in PH, temperature and gases. Thus these chemosensors help regulate respiratory activity. Cibiem is a company which has a proprietary technology for sympathetic modulation carotid body through minimally invasive technique. Technically the procedure can provide relief from a broad range of conditions such as hypertension, heart failure, diabetes and renal failure since they arise through the sympathetic nervous system of the body. The idea of modulating the carotid body to have an effect on the sympathetic nervous system mediated diseases was first carried out sometime in the 1940?s but was carried through an open surgery and was still carried out in the 1990?s. Cibiem raised US$ 10 million to carry out first-in-man trials in Wroclaw Poland, where the device was being tested for efficacy in heart failure in August 2012. The company is backed by Venture Capitalist firms such as SV life Sciences, Third Rock Ventures and consulted by Coridea, which was also involved in the formation of Ardian Systems that was acquired by Medtronic for its renal denervation technology Symplicity. Coridea is an incubator, idea generator consulting firm that targets new technologies in the cardio-renal and cardio-pulmonary areas of medicine. Hypertension is a known cause of renal damage and chronic kidney disease. There are over 1.2 billion people over the world living with hypertension. The Center for Disease Control (CDC) states that over 700,000 people in United States only.

Free Sample Report@

Around 5.7 million people have heart failure events every year, which costs the state over USD 34 billion in healthcare costs per year. The incidence rate is growing due to increased stress and lifestyle of the population, increasing population among other lifestyle related diseases. By 2020, over 50 million people are expected to be at risk of heart failure, since the consumption of cigarettes have also been on the rise. Smoking has been proven to be a major causative factor of heart failure by World Health Organization, Center for Disease Control and National Institutes of Health. Since there is only one proprietor in this market, the opportunities for large companies to create strategies for acquiring this idea are large. Considering the potential of the device which caters to common diseases occurring in large populations, the market is expected to be worth billions post its device approval. Since its In-Man trials began last year, hopefully the device would enter the market sometime by mid-2017 to 2018.

Click For Request TOC@

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research on Carotid Body Modulation Devices Market Forecast and Analysis Till 2020 here

News-ID: 418434 • Views: 481

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Device

Walking Assist Device
The Walking Assist Device Market 2018 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Walking Assist Devicese industry. First, " Walking Assist Devicese Industry 2018" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Walking Assist Devicese industry chain structure. Walking Assist Device Market Top Players Honda Motor Co., Ltd., Permobil
Molded Interconnect Device Market
Molded Interconnect Device Market-Global Industry Analysis and Forecast (2018-2026) by Process, Product Type, End-user application and geography Molded Interconnect Device Market was valued US$ 300 Mn in 2017 and is expected to reach US$ 890.5 Mn by 2026 at a CAGR of 14.57% during forecast period. Molded Interconnect Device market is segmented by process, product, end-user application and region. Increasing demand in electrical and mechanical application, rising use of Molded Interconnect Device
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in
Timing Device Market
Asia Pacific traffic sensor market is expected to hold the majority share due to the adoption of technologically-advanced systems. Growing urban population and the increasing need for real-time information systems in the region will propel the traffic sensor market growth. Growing urban population in countries including India, China, Japan, and South Korea is increasing the strain on the traffic management solutions. This is encouraging the governments to invest increasingly in
Neurorehabilitation Devices - MIME Robotic Device
Bioness Inc., Bionik Laboratories Corp., Bioxtreme, Denecor, Ectron Ltd., Ekso Bionics, Helius Medical Technologies, Hocoma AG, MagVenture A/S, Medtronic, Neuro Style, Rehab-Robotics Company Limited, Rehabtronics Inc, St Jude Medical Inc., Tyromotion are some of the prominent players at the forefront of competition in the global Neurorehabilitation Devices Market and are profiled in MRFR Analysis. Global Neurorehabilitation Devices Market - Overview The neurorehabilitation devices market is growing with the rapid pace. According
Global Medical Device Connectivity Market
Global Medical Device Connectivity Market, By Type (Integration Software, Connectivity Hardware (Wired, Wireless (Wi-Fi, WMTS, Bluetooth), By Applications (Electronic Medical Record, Patient Monitoring, Others), By End-User (Hospitals, Community Healthcare, Clinics, Others), By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024 The Global Medical Device Connectivity Market has accounted for USD 5.7 billion in 2016 and is expected to reach